Renal conditions

Educational resources

Trajenta animation updated index image

Prescribing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.
View Trajenta (linagliptin) adverse event reporting and prescribing information for Great Britain or Northern Ireland
PC-GB-105090 Date of preparation: October 2021